[HTML][HTML] Liposome-based dry powder vaccine immunization targeting the lungs induces broad protection against pneumococcus

TC Rodrigues, DB Figueiredo, VM Gonçalves… - Journal of Controlled …, 2024 - Elsevier
Streptococcus pneumoniae is an important human pathogen. Currently used conjugate
vaccines are effective against invasive disease, but protection is restricted to serotypes …

[HTML][HTML] Nasal delivery of encapsulated recombinant ACE2 as a prophylactic drug for SARS-CoV-2

A Baldelli, CYJ Wong, H Oguzlu, H Gholizadeh… - International Journal of …, 2024 - Elsevier
Abstract Angiotensin-converting enzyme 2 (ACE2) is responsible for cell fusion with SARS-
CoV viruses. ACE2 is contained in different areas of the human body, including the nasal …

Development of Large Hollow Particles for Pulmonary Delivery of Cyclosporine A

Y Huang, H Tang, X Meng, Z Zhao, Y Liu, D Liu… - Pharmaceutics, 2023 - mdpi.com
The purpose of this study was to prepare large hollow particles (LHPs) by spray drying for
pulmonary delivery of cyclosporine A (CsA), using L-Leucine (LEU) and hydroxypropyl …

Building respirable powder architectures: utilizing polysaccharides for precise control of particle morphology for enhanced pulmonary drug delivery

K Kadota, H Uchiyama, T Kämäräinen… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Dry powder inhaler (DPI) formulations are gaining attention as universal
formulations with applications in a diverse range of drug formulations. The practical …

Formulation of Resveratrol-Loaded Polycaprolactone Inhalable Microspheres Using Tween 80 as an Emulsifier: Factorial Design and Optimization

R Mahar, A Chakraborty, N Nainwal - AAPS PharmSciTech, 2023 - Springer
Resveratrol (RSV) is a bioactive phytoconstituent that has potential applications in
respiratory diseases. However, poor oral bioavailability is the major hurdle to its clinical use …

Dry powder inhalation containing muco-inert ciprofloxacin and colistin co-loaded liposomes for pulmonary P. Aeruginosa biofilm eradication

J Wang, Y Guo, W Lu, X Liu, J Zhang, J Sun… - International Journal of …, 2024 - Elsevier
Pseudomonas aeruginosa (PA), a predominant pathogen in lung infections, poses
significant challenges due to its biofilm formation, which is the primary cause of chronic and …

Surface modification strategies for high-dose dry powder inhalers

H Park, ES Ha, MS Kim - Journal of Pharmaceutical Investigation, 2021 - Springer
Background There is a growing interest in the use of dry powder inhalers (DPIs) for
administering high-dose drugs with low potency to the lungs as carrier-free formulations to …

Engineering Inhalable Therapeutic Particles: Conventional and Emerging Approaches

A Negi, S Nimbkar, JA Moses - Pharmaceutics, 2023 - mdpi.com
Respirable particles are integral to effective inhalable therapeutic ingredient delivery,
demanding precise engineering for optimal lung deposition and therapeutic efficacy. This …

Preparation strategies of the anti-mycobacterial drug bedaquiline for intrapulmonary routes of administration

SE Maloney, IE Stewart, BK Podell, HE Gary… - Pharmaceuticals, 2023 - mdpi.com
Mycobacterium tuberculosis (M. tb) has infected one-quarter of the world's population and
led to the deaths of 1.6 million individuals in 2021 according to estimates from the World …

Nanodispersions for drug delivery applications: a special focus toward cancer therapeutics

V Sethuraman, A Ramesh, K Janakiraman… - Journal of Nanoparticle …, 2024 - Springer
Nanotechnology has expanded in drug delivery applications in recent years due to inherent
features such as drug compatibility, improved solubility/bioavailability of poorly soluble …